Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): Study protocol for a randomised controlled trial

Juan Carlos Villar, Víctor Mauricio Herrera (Co-author), Juan Guillermo Pérez Carreño (Co-author), Eliana Váquiro Herrera (Co-author), Yeny Zulay Castellanos Domínguez (Co-author), Skarlet Marcell Vásquez (Co-author), Zulma Milena Cucunubá (Co-author), Nilda Graciela Prado (Co-author), Yolanda Hernández (Co-author)

Research output: Articles / NotesComment/debate

22 Scopus citations

Fingerprint

Dive into the research topics of 'Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): Study protocol for a randomised controlled trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science